CytomX Therapeutics (6C1.F) Q1 2025 Earnings

6MarConfirmed
Q2 2024
Q3 2024
Q4 2024
Q1 2025
-0.18
-0.05
0.08
0.2

Details

Expected EPS
-0.181032903
Actual EPS
0.20394
Surprise EPS
0.38
Surprise Percent
+212.65%

Description

CytomX Therapeutics (6C1.F) has reported earnings of 0.20394 per share for Q1 2025.

0 Comments

Share your thoughts